IRIS
CIOFINI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.241
NA - Nord America 1.045
AS - Asia 639
SA - Sud America 134
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 54
OC - Oceania 1
Totale 3.200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.010
IT - Italia 377
RU - Federazione Russa 366
SG - Singapore 214
CN - Cina 162
IE - Irlanda 127
BR - Brasile 106
GB - Regno Unito 102
VN - Vietnam 65
DE - Germania 60
FR - Francia 53
HK - Hong Kong 52
FI - Finlandia 43
SE - Svezia 41
KR - Corea 30
IN - India 26
NL - Olanda 23
CA - Canada 21
ZA - Sudafrica 21
BD - Bangladesh 18
AR - Argentina 16
IQ - Iraq 15
EG - Egitto 13
ES - Italia 10
JP - Giappone 9
PL - Polonia 9
AT - Austria 8
MA - Marocco 8
CZ - Repubblica Ceca 6
IR - Iran 6
TR - Turchia 6
KE - Kenya 5
MX - Messico 5
SA - Arabia Saudita 5
BO - Bolivia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LT - Lituania 3
PY - Paraguay 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CO - Colombia 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
JM - Giamaica 2
LV - Lettonia 2
MY - Malesia 2
NG - Nigeria 2
PE - Perù 2
PK - Pakistan 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MN - Mongolia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.115
Salva come PNG Salva come JPEG
Città #
Singapore 139
Dallas 137
Dublin 126
San Jose 110
Ashburn 107
Moscow 101
Milan 82
Santa Clara 71
Council Bluffs 69
Southend 50
Hefei 49
Hong Kong 48
Chandler 47
Florence 42
Beijing 37
Los Angeles 36
Seoul 30
Siena 30
The Dalles 29
New York 27
Lauterbourg 23
Munich 22
Ho Chi Minh City 18
Hanoi 17
Helsinki 17
Johannesburg 17
Rome 16
Lappeenranta 15
Fairfield 14
Turin 14
Princeton 13
Portsmouth 12
Frankfurt am Main 11
Turku 11
Columbus 10
Buffalo 9
London 9
Orem 9
Seattle 9
Atlanta 8
Düsseldorf 8
Montreal 8
Phoenix 8
Washington 8
Woodbridge 8
Bengaluru 7
Naples 7
North Bergen 7
Redondo Beach 7
Sulaymaniyah 7
Tokyo 7
Warsaw 7
Haiphong 6
Houston 6
São Paulo 6
Tehran 6
Cairo 5
Chennai 5
Denver 5
Nuremberg 5
Poplar 5
San Diego 5
Shanghai 5
Spoltore 5
Wilmington 5
Boston 4
Brooklyn 4
Cagliari 4
Chicago 4
Fremont 4
Miami 4
Modena 4
Newark 4
Toronto 4
Agnano 3
Almaty 3
Amsterdam 3
Baghdad 3
Barnet 3
Belo Horizonte 3
Bergamo 3
Biên Hòa 3
Bologna 3
Bolzano 3
Brno 3
Buenos Aires 3
Cambridge 3
Figino 3
Genova 3
Islington 3
Nanjing 3
Palermo 3
Paullo 3
Pisa 3
Ponte a Egola 3
Redditch 3
Rio de Janeiro 3
San Francisco 3
Tashkent 3
The Hague 3
Totale 1.913
Salva come PNG Salva come JPEG
Nome #
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia 296
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network 230
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia 225
Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia 214
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma 211
Anti CD38 monoclonal antibodies for multiple myeloma treatment 208
New prognostic markers in acute myeloid lekemia: focus on BCL2 expression 205
Fludarabine, high-dose cytarabine and idarubicin-based induction may overcome the negative prognostic impact of FLT3-ITD in NPM1 mutated AML, irrespectively of FLT3-ITD allelic Burden 186
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network) 184
Functional imaging in the evaluation of treatment response in multiple myeloma: the role of PET-CT and MRI 165
Monoclonal gammopathy of renal significance (MGRS): real-world data on outcomes and prognostic factors 157
Anti-BCMA novel therapies for multiple myeloma 147
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications 142
Real-life experience with pomalidomide plus low-dose dexamethasone in patients with relapsed and refractory multiple myeloma: a retrospective and prospective study 141
Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation 139
Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies 135
Intensive Fludarabine, High Dose Cytarabine and Idarubicin-Based Induction for Younger NPM1-Mutated AML Patient: Overcoming the Negative Prognosis of FLT3-ITD Mutation 109
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM 33
Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensus 30
Efficacy and Safety of Teclistamab Followed by Autologous Stem Cell Transplant in Functional High-risk and Triple-class Refractory Multiple Myeloma 25
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis 18
Totale 3.200
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.027
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022101 0 5 6 13 2 4 5 4 3 19 16 24
2022/2023223 13 22 22 20 12 27 9 31 18 3 29 17
2023/2024317 12 9 36 28 14 66 88 12 5 12 8 27
2024/2025697 31 24 76 45 69 54 23 53 67 54 83 118
2025/20261.670 98 174 142 236 354 64 147 47 61 130 80 137
2026/2027125 96 29 0 0 0 0 0 0 0 0 0 0
Totale 3.200